- Home
- FENC vs HYI Comparison
FENC vs HYI Comparison
Compare FENC & HYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- HYI
- Stock Information
- Founded
- FENC 1996
- HYI 2010
- Country
- FENC United States
- HYI United States
- Employees
- FENC N/A
- HYI N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- HYI Investment Managers
- Sector
- FENC Health Care
- HYI Finance
- Exchange
- FENC Nasdaq
- HYI Nasdaq
- Market Cap
- FENC 234.9M
- HYI 272.7M
- IPO Year
- FENC 2001
- HYI N/A
- Fundamental
- Price
- FENC $8.01
- HYI $11.28
- Analyst Decision
- FENC Strong Buy
- HYI
- Analyst Count
- FENC 2
- HYI 0
- Target Price
- FENC $13.50
- HYI N/A
- AVG Volume (30 Days)
- FENC 111.8K
- HYI 50.6K
- Earning Date
- FENC 11-13-2025
- HYI 01-01-0001
- Dividend Yield
- FENC N/A
- HYI 9.59%
- EPS Growth
- FENC N/A
- HYI N/A
- EPS
- FENC N/A
- HYI N/A
- Revenue
- FENC $38,790,000.00
- HYI N/A
- Revenue This Year
- FENC N/A
- HYI N/A
- Revenue Next Year
- FENC $64.79
- HYI N/A
- P/E Ratio
- FENC N/A
- HYI N/A
- Revenue Growth
- FENC N/A
- HYI N/A
- 52 Week Low
- FENC $3.96
- HYI $10.99
- 52 Week High
- FENC $9.92
- HYI $12.24
- Technical
- Relative Strength Index (RSI)
- FENC 41.09
- HYI 31.28
- Support Level
- FENC $7.53
- HYI $11.28
- Resistance Level
- FENC $8.42
- HYI $11.39
- Average True Range (ATR)
- FENC 0.47
- HYI 0.07
- MACD
- FENC -0.04
- HYI 0.00
- Stochastic Oscillator
- FENC 20.86
- HYI 0.00
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About HYI Western Asset High Yield Defined Opportunity Fund Inc.
Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. The fund invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.